Air Canada (TSX:AC) Stock Spikes 68% in November: Should You Buy Now?

Air Canada stock witnessed strong buying in November, as investors remain hopeful on COVID-19 vaccine.

| More on:
An airplane on a runway

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Air Canada (TSX:AC) stock sank in 2020, as travel restrictions amid the rapid spread of the coronavirus pandemic weighed heavily on its operations. However, November marked immense buying in Air Canada on the positive vaccine data, which led to a 68% jump in its stock in one month. 

Investors remain hopeful that an effective coronavirus vaccine could drive travel demand and lead to a quick recovery in Air Canada stock. However, is the rally in Air Canada stock sustainable, or will continued uncertainty drag it down?

Gradual recovery

While the passenger traffic fell drastically in 2020, Air Canada’s Q3 numbers showed a sequential improvement, thanks to the resumption of domestic operations and steep cost-reduction measures. Its Q3 revenues plunged 86% year over year to $757 million. However, it jumped approximately 44% on a quarter-over-quarter basis. 

What impressed me is the sharp decline in its net cash burn rate. Air Canada reported a net cash burn of $818 million or $9 million per day in Q3, which is way better than the preceding quarter’s net cash burn of $1.72 billion, or about $19 million per day. It also came narrower than management’s forecast range of $1.35 billion to $1.6 billion. Air Canada’s operating loss of $785 million narrowed down significantly from $1.56 billion in Q2. 

The improved numbers reflect Air Canada’s company-wide cost-reduction and deferral program, which led to a decline of $3.03 billion, or 66% in its operating expenses. 

With unlocking measures and a gradual pickup in demand, we could witness Air Canada increasing its capacity sequentially. However, the prevailing coronavirus situation is likely to restrict passenger traffic in the coming months. 

Challenges to persist

While an effective vaccine is on the horizon, it’s too early to say that airline stocks will sustain the uptrend, as it would take several months for a vaccine to reach the general public. Besides, the structural shift towards remote work could hurt the aviation and travel industry, even in the post-pandemic world. 

With the resumption of domestic operations, Air Canada has marked sequential recovery. However, passenger traffic remains weak on a year-over-year basis. Air Canada registered a year-over-year decline of 88% in passengers carried in the most recent quarter. Meanwhile, its capacity, measured through available seat miles, plunged 81.7% year over year. 

Air Canada plans to lower its capacity by 75% in Q4 amid international border closures and weak demand. Moreover, the passenger airline company expects its net cash burn rate to rise sequentially. It projects net cash burn to be in the range of $1.1 billion and $1.3 billion or between $12 million and $14 million per day in Q4. 

Final thoughts 

While the above numbers look scary, Air Canada could tide over the crisis with the gradual pickup in demand, significant cost reductions, and robust liquidity. Meanwhile, an effective vaccine could step up the recovery pace. However, I must stress that investors with a medium- to long-term outlook should only consider buying Air Canada stock, as it is likely to remain highly volatile in the short term. Investors could use a pullback in Air Canada stock to go long for exceptional returns. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »